41 – 50 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
(
- Contribution to journal › Letter
-
Mark
Editorial : Asthma: a modifiable disease on a crossroad
(
- Contribution to journal › Article
-
Mark
Point-of-care biomarkers in asthma management : Time to move forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Research Priorities in Pediatric Asthma : Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
(
- Contribution to journal › Scientific review
-
Mark
The need for clean air : The way air pollution and climate change affect allergic rhinitis and asthma
(
- Contribution to journal › Scientific review
-
Mark
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
(
- Contribution to journal › Article
-
Mark
Letter to the editor : Indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: A randomized controlled cross-over study
(
- Contribution to journal › Article
-
Mark
COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series
(
- Contribution to journal › Letter
- 2019
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review